How to Buy Genedx Holdings Stock
Genedx Holdings Corp
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories.
Genedx Holdings stock last closed at $121.87, down 5.28% from the previous day, and has increased 242.43% in one year. It has overperformed other stocks in the Health Information Services industry by 3.04 percentage points. Genedx Holdings stock is currently +322.28% from its 52-week low of $28.86, and -6.49% from its 52-week high of $130.33.
There are currently 28.73M shares of WGS outstanding. The market cap of WGS is $3.50B. In the last 24 hours, 626,000 WGS shares were traded.
How to Buy Genedx Holdings Stock
Not sure how to invest in Genedx Holdings stock? Here's how.
- Figure out where to buy Genedx Holdings stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you choose where to buy Genedx Holdings stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Put funds into your brokerage account: Select your payment method and add your information.
- Analyze Genedx Holdings stock: The Genedx Holdings ticker symbol is WGS. Is Genedx Holdings stock a good investment? Should you buy shares of WGS? How do WGS's underlying business fundamentals look? Do top analysts think Genedx Holdings is a good buy? Why has WGS's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if WGS is a good stock to buy).
- Place your WGS buy order: Decide if you will purchase WGS shares at the current market price or use a limit order to buy WGS shares at a given price.
- Keep an eye on your WGS investment: Create a watchlist to keep tabs on your position in Genedx Holdings stock.
Step 1: Figure out where to buy Genedx Holdings stock
You need a brokerage account in order to access the NASDAQ market and buy WGS shares.
Our preferred brokerage: eToro
Based on our research, eToro is the best online stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global financial markets: From Technology to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal info so you can buy WGS today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to create a new trading account.
- Send your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've filled out your info on the greatest app to buy stocks, you can securely and quickly fund your account:
Check out this video walkthrough if you need help depositing money into your new investment account.
Step 4: Analyze Genedx Holdings stock
After you have figured out the best place to buy Genedx Holdings stock, it's important to evaluate their stock before you buy, so you can understand the risk as well as the opportunity.
Genedx Holdings stock quick numbers
Genedx Holdings Due Diligence Checks
WallStreetZen was created to help part-time investors do better fundamental analysis.
You can see all of the due diligence checks on WGS's stock page.
Is WGS stock overvalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge WGS's intrinsic value.
Using relative valuations measures:
- WGS may be overvalued based on its P/E ratio of 1,741x, relative to Health Information Services industry P/E ratio of 81.72x
- WGS could be overvalued based on its P/B ratio of 12.63x, relative to Health Information Services industry P/B ratio of 4.13x
- WGS may be overvalued based on its PEG ratio of 4.18x
You can access more valuation research on WGS's stock here.
WGS Financial Overview
Pros:
- There are more short-term assets than long-term liabilities on the WGS balance sheet.
- There are more short-term assets than short-term liabilities on the WGS balance sheet.
- WGS profit margin has gone up from -48.2% to 0.4% in the past year.
Cons:
- WGS earnings of $4.53M is not enough to cover its interest payments.
- WGS's operating cash flow of $13.02M allows it to safely service it's debt of $114.39M.
- WGS has a relatively high debt to equity ratio of 0.67.
Is WGS stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 5 Equities analysts who research WGS, the consensus analyst rating on WGS is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Genedx Holdings stock forecast page.
WGS Trading Indicators
WGS Earnings
Last year, WGS earnings were $1.41M. In the last four year, WGS's earnings have increased by -99.16% per year. This was slower than the Health Information Services industry average of 10.91%.
Last year, WGS revenue was $362.32M. In the past 4 year, WGS's revenue has gone up by 14.1% per year. This was slower than the Health Information Services industry average of 24.64%.
Dive into WGS's earnings and revenue performance here.
Who is buying/selling WGS?
Over the past 12 months, insiders at WGS have sold more shares than they have bought.
Casdin Capital LLC, Director of WGS, was the latest WGS insider to sell. They sold $60,452,000.00 worth of WGS shares on Aug 22, 2025.
Research more about who owns WGS shares here.
Can I rely on WGS as an income stream?
No, Genedx Holdings doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your WGS buy order
There are two main order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are usually the best for newer investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a specific dollar amount, use a limit order.
Click the Open button and your broker will place your order.
If you need more assistance buying stocks on eToro, watch the helpful video below:
Step 6: Keep an eye on your WGS investment
Now that you own some WGS stock, you'll want to keep up with your new company.
Add WGS to a watchlist to get the latest updates about your WGS stock.
WGS Feed
How to Buy Stock in Genedx Holdings
To summarize, here are the 6 steps to buy Genedx Holdings stock:
- Figure out where to buy Genedx Holdings stock
- Open a brokerage account
- Put funds into your brokerage account
- Analyze Genedx Holdings stock
- Place your WGS buy order
- Keep an eye on your WGS investment
If you need a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you want to get the latest news on your new investment in Genedx Holdings, add WGS to your watchlist by clicking the button below.
Trending Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.